Navigation Links
Genzyme Reports Strong Second-Quarter Growth
Date:7/23/2008

Due to Investment

Common Stock in Equity

NON-GAAP Equivalents Securities

Income Statement Classification:

Total revenues $1,171,134

Cost of products and services sold $(294,019)

Selling, general and administrative $(315,401)

Research and development $(190,769)

Amortization of intangibles $-

Purchase of in-process research

and development $-

Equity in income (loss) of equity

method investments $-

Minority interest $563

Gains (losses) on investments in

equity securities $138 $9,015

Other $19

Investment income $13,352

Interest expense $(1,149)

Summary:

Income (loss) before income taxes $383,868 $- $9,015

(Provision for) benefit from

income taxes $(115,322) $- $(3,283)

Net income (loss) $268,546 $- $5,732

Net income (loss) per share:

Basic $1.01 $- $0.02

Diluted (1) $0.98 $(0.03) $0.02

Weighted average shares outstanding:

Basic 266,904

Diluted (1) 274,576 9,686

License FAS 123R GAAP

Fee Amortization Expense As Reported

Income Statement

Classification:

Total revenues $1,171,134

Cost of products and<
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
2. Genzyme Begins Major Expansion of Boston Manufacturing Facility
3. Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
4. Genzyme Receives Approval to Market Elaprase(R) in Japan
5. Genzyme Recognized by Scientists as a Top Employer
6. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
7. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
8. Genzyme Launches Cholestagel(R) in Europe
9. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
10. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Philadelphia’s newest entrepreneurial incubation space is ready for ... The Innovation Center @3401 , a collaborative effort of ... to help attract and nurture start-up businesses in the ... , The Innovation Center @3401 (ic@3401), which is ... the new home of DreamIt Ventures and ...
(Date:7/29/2014)... -- United Therapeutics Corporation (NASDAQ: UTHR ... the second quarter ended June 30, 2014. ... medicines are reaching increasing numbers of patients ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and ... quarter of our extended-release tablet called Orenitram ...
(Date:7/29/2014)... 2014 Dr. Jason Wendel – recipient of ... one of the Top 10 Plastic Surgeon Specialists for Nashville, ... products. His complete line includes a Hydration Booster, Retexturing Night ... face and skin a younger, more radiant appearance while protecting ... is different, that is why at Dr. J. J. Wendel ...
(Date:7/28/2014)... DIEGO , July 28, 2014 ... cultivation technologies, today announced the appointment of biotechnology veteran ... of the board of directors. Levine replaces Cynthia ,CJ, ... immediately. She will remain chairman of the company,s board ... on Sapphire Energy,s mission to deliver commercial scale algae-based ...
Breaking Biology Technology:Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 2Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 3United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 11United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 12United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 13Dr. J. J. Wendel Launches New Line of Skin Care Products 2Sapphire Energy Announces New CEO James Levine 2Sapphire Energy Announces New CEO James Levine 3
... Rice University,s award-winning undergraduate summer research program NanoJapan ... $4 million grant from the National Science Foundation ... from all U.S. universities, combines a traditional study-abroad ... internship in nanotechnology. The program was created in ...
... Sept. 21 Oxford Resource Partners, LP (NYSE: ... today announced their collaborative agreement to develop a pilot ... previously reclaimed from mining operations by Oxford. The goal ... economic viability of biomass production from dedicated energy crops ...
... JERUSALEM, Sept. 21 Chiasma, Inc., a privately ... CEO, will present an overview of the Company at the ... York, New York, on Wednesday, September 22, 2010 at 11:00 ... clinical trial of the investigational new drug Octreolin™, an oral ...
Cached Biology Technology:Rice University's award-winning NanoJapan program wins $4M grant 2Rice University's award-winning NanoJapan program wins $4M grant 3Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio 2Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio 3Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio 4Chiasma to Present at the UBS Global Life Sciences Conference 2Chiasma to Present at the UBS Global Life Sciences Conference 3
(Date:7/29/2014)... bacteria and algae, propel themselves using whip-like appendages ... a millimetre long, function like tiny oars, helping ... cilia are found on the surfaces of many ... liquids over the cell. , Flagella and ... expel pathogens from our airways, they establish the ...
(Date:7/28/2014)... by the U.S. Food and Drug Administration (FDA) for ... bacterial pathogens inside human cells, including those that cause ... published in mBio , the online open-access journal ... way of identifying non-antibiotic drugs that could one day ... drugs on the list inhibit the growth of at ...
(Date:7/28/2014)... reached the South Pole in 1911, but new research ... human. , Using data from 16 ice cores collected ... the South Pole, a group led by Joe McConnell ... created the most accurate and precise reconstruction to date ... record, described in an article published today in the ...
Breaking Biology News(10 mins):Microscopic rowing -- without a cox 2Microscopic rowing -- without a cox 3New route to identify drugs that can fight bacterial infections 2Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3
... ranging from the shellfish Swedish people eat at traditional ... their millions in both freshwater and saltwater. One of ... crustacean to have its genome sequenced. A researcher from ... The sequencing has been done in an international ...
... of cancer deaths resulted from metastasis, the spread of ... exploration of the possible mechanical factors that promote metastasis ... is expanding the scientific understanding of what makes malignant ... fibrous matrix that surrounds cancer cells. Karen ...
... SPRING HARBOR, N.Y. (March 22, 2011) - An ... to scientists and nonscientists alike. Its behavior involves processes ... those external to itenvironment and social surroundings. According to ... tapestry of biology: It is sparked when neurons fire ...
Cached Biology News:Surprising results in the first genome sequencing of a crustacean 2WSU proves extracellular matrix tugging creates come hither stimulus for cancer migration 2New book on animal behavior provides integrated view 2
...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, Molecular Biology Grade...
... moderate chemiluminescence efficiencies and the chemistry of ... the added benefit that they require simple ... background signal. This benefit has been exploited ... applications. These compounds can also be easily ...
... Deletion Kit for Kilo-Sequencing is designed to ... cloned into the multiple cloning sites (MCS) ... plasmid or phagemid vectors (pUC18/19). The kit ... in the target DNA, thereby progressively moving ...
Biology Products: